Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof

Details for Australian Patent Application No. 2002250997 (hide)

International Classifications

Event Publications

20 March 2003 Application Open to Public Inspection

Published as AU-B-2002250997

15 December 2005 Assignment before Grant

Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

9 March 2006 Application Accepted

Published as AU-B-2002250997

6 July 2006 Standard Patent Sealed

18 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.